Company Description

SunVax offers an innovative lipid nanoparticle (LNP) delivery technology that leverages an extensive self-amplifying mRNA (SamRNA) platform to advance mRNA medicines in oncology, vaccines, autoimmune diseases and rare diseases, maximizing the potential for transformative medical breakthroughs.